Search Results
Jun 11, 2026, 07:00 ET Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026
trial-in-progress poster on the MAIA-ovarian Phase 1 study of COM701, a potential first-in-class anti-PVRIG antibody, at the ESMO Gynaecological Cancers Congress 2026, taking place from June 17 to June 19, 2026, in Copenhagen, Denmark. Poster details: Title: MAIA-ovarian (NCT06888921)
More news about: Compugen Ltd.
Jun 09, 2026, 05:13 ET Whole-Body Spatial Intelligence Beyond Weight-loss: nference Advances Cardiometabolism Moat for Precision Peptide Medicines and Healthy Longevity
https://www.researchsquare.com/article/rs-9407186/v1About MAIAThe Metabolism Agentic Intelligence Atlas (MAIA) is an nference strategic initiative focused on making cardiometabolism computable across therapies, diseases, organs, and patient trajectories. By integrating federated real-world data with AI-enabled clinical phenotyping, MAIA maps
More news about: nference
Jun 09, 2026, 01:59 ET XCMG CONNECT Hubungkan Pelanggan, Alat Berat, dan Lokasi Kerja Menjadi Sebuah Ekosistem Layanan Industri Digital
independen, Maia mewujudkan interaksi alami antara manusia dan mesin, layaknya seorang ahli teknik yang selalu mendampingi pelanggan.XCMG ONE merupakan aplikasi seluler yang dirancang khusus untuk pengguna internasional. Aplikasi ini mengintegrasikan fitur-fitur utama agen AI Maia yang mendorong
More news about: XCMG
Jun 08, 2026, 10:47 ET Kết nối mọi khách hàng, mọi thiết bị, mọi công trường: XCMG CONNECT tái định hình hệ sinh thái dịch vụ công nghiệp
dựngMaia, tác nhân AI thông minh đa ngôn ngữ và có khả năng cộng tác của XCMG, kết hợp học sâu với chuyên môn kỹ thuật để thực hiện các chẩn đoán thiết bị, phát hiện lỗi tự động và tối ưu hóa vận hành dựa trên dữ liệu. Có thể truy cập thông qua màn hình AI thông minh do XCMG tự phát triển, Maia mang
More news about: XCMG
Jun 08, 2026, 07:00 ET Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development
randomized ovarian cancer platform trial evaluating COM701 as a single agent in maintenance therapy in relapsed platinum sensitive ovarian cancer (named MAIA-ovarian trial). Rilvegostomig, a PD-1/TIGIT bispecific antibody with a TIGIT component that is derived from COM902 program, is being developed by AstraZeneca
More news about: Compugen Ltd.
May 19, 2026, 21:15 ET Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
Protaigé delivers autonomous marketing execution at scale, with Maia running the platform on behalf of marketers from channels they already use.SINGAPORE, May 20, 2026 /PRNewswire/ --
More news about: Protaigé
May 19, 2026, 21:15 ET Autonomous AI marketing platform Protaigé launches with Maia, the world's first AI Account Director that operates within the flow of work
Protaigé delivers autonomous marketing execution at scale, with Maia running the platform on behalf of marketers from channels they already use.SINGAPORE, May 19, 2026 /PRNewswire/ --
More news about: Protaigé
May 18, 2026, 07:00 ET Compugen Reports First Quarter 2026 Results
COM701 MAIA-ovarian trial actively enrolling patients across all clinical sites in the U.S., Israel, and France; interim analysis on track by Q1 2027Partner AstraZeneca is advancing rilvegostomig across 11 ongoing Phase 3 trials and presented clinical and pre-clinical rilvegostomig
More news about: Compugen Ltd.
May 15, 2026, 13:08 ET Growth Catalyst Group Appoints Maia Benson as Chief Commercial Officer
/PRNewswire/ -- Growth Catalyst Group of Companies (GCG), a global leader and investor in supply chain technology, today announced the appointment of Maia Benson as Chief Commercial Officer (CCO). Benson brings more than 20 years of experience building and scaling SaaS and logistics businesses in high-growth
More news about: Growth Catalyst Group
May 15, 2026, 13:01 ET Growth Catalyst Group Appoints Maia Benson as Chief Commercial Officer
/PRNewswire/ -- Growth Catalyst Group of Companies (GCG), a global leader and investor in supply chain technology, today announced the appointment of Maia Benson as Chief Commercial Officer (CCO). Benson brings more than 20 years of experience building and scaling SaaS and logistics businesses in high-growth
More news about: Growth Catalyst Group
May 12, 2026, 07:00 ET Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum
randomized ovarian cancer platform trial evaluating COM701 as a single agent in maintenance therapy in relapsed platinum sensitive ovarian cancer (named MAIA-ovarian trial). Rilvegostomig, a PD-1/TIGIT bispecific antibody with a TIGIT component that is derived from COM902 program, is being developed by AstraZeneca
More news about: Compugen Ltd.
May 05, 2026, 09:00 ET ACE Venture Completes 51% Acquisition of Vireo Health New York, Uniting Corporate Infrastructure With Cultural Vision and Launching Boukét as New York's Premier Cannabis Lifestyle Brand
finance, law, design, entertainment, and experiential development, because the most enduring brands are built by the most intentional people. From Roy and Maia Nachum, the visionary minds behind Mercer Labs, shaping the physical experience of ACE dispensaries, to Craft Cartel founders Kenji Fujishima and Arthur
More news about: Boukét
May 04, 2026, 07:00 ET Compugen to Release First Quarter 2026 Results on Monday, May 18, 2026
randomized ovarian cancer platform trial evaluating COM701 as a single agent in maintenance therapy in relapsed platinum sensitive ovarian cancer (named MAIA-ovarian trial). Rilvegostomig, a PD-1/TIGIT bispecific antibody with a TIGIT component that is derived from COM902 program, is being developed by AstraZeneca
More news about: Compugen Ltd.
Apr 30, 2026, 15:49 ET Wegovy® é mais eficiente em preservar massa muscular durante a perda de peso, mostram novos estudos de vida real
qualidade, com menor comprometimento da massa magra e da função muscular, quando comparada à tirzepatida. Estudo divulgado em abril de 2026 pela iniciativa MAIA (Metabolism Agentic Intelligence Atlas), nos EUA, revela dados de vida real, com aproximadamente 8.000 pacientes com medidas de composição corporal
More news about: Novo Nordisk
Apr 28, 2026, 09:00 ET Dr. Leti Romo Joins Alliant University as Director of Inclusion & Community Relations
faculty who practice what they teach, a culture of belonging, and a track record of innovation across higher education.Media Contact:Maia Kelly-MolinaDirector of Strategic CommunicationsAlliant University
More news about: Alliant University
Apr 20, 2026, 09:12 ET Tampax spotlights all-star athlete lineup led by Olivia Miles, bringing "Queen's Court" fan experience to women's basketball's biggest moments
selected as the No. 2 overall pick in the 2026 WNBA Draft, cementing her status as a rising star at the professional level.About Maia ShibutaniMaia Shibutani is a two-time Olympic medalist, author, producer, and speaker. Alongside her brother and ice dance partner Alex Shibutani, she
More news about: Tampax
Apr 08, 2026, 09:02 ET Board-Certified Plastic Surgeon Dr. Munique Maia Offering Scarless Endoscopic Facelift at Northern Virginia Practice
Munique Maia has expanded the range of surgical facial rejuvenation procedures at Maia Plastic Surgery in Tysons Corner, Virginia, offering the scarless endoscopic facelift. Trained under the guidance of internationally recognized surgeon and Ponytail Lift pioneer Dr. Chia Chi Kao, Dr. Maia offers patients
More news about: Maia Plastic Surgery
Apr 07, 2026, 14:48 ET Introducing Fair Play: The World's First Digital Prosecutor Powered by Artificial Intelligence
problem, but to facilitate access to justice and drive tangible change. It is creatively applied to building a more equitable society," added Renata Maia, Chief Creative Officer of Ogilvy Health.Anyone can use the platform. By accessing
More news about: Ogilvy & Mather Worldwide
Apr 02, 2026, 10:17 ET Clinical AI Announces the Launch of MAIA™ Prescreening on Google Cloud Marketplace
multimedia:https://www.prnewswire.com/news-releases/clinical-ai-announces-the-launch-of-maia-prescreening-on-google-cloud-marketplace-302732165.htmlSOURCE
More news about: Clinical AI
Mar 26, 2026, 14:32 ET Matillion Launches Maia's Migration Agent: Autonomous Migration for Legacy ETL Platforms
now.About MaiaMaia is Matillion's
More news about: Matillion Ltd
Mar 26, 2026, 09:00 ET Alliant University Earns Full California Teacher Credentialing Accreditation from State Commission
Denver J. Fowler, the Alliant School of Education aspires to prepare educators capable of inspiring generations to come.Media Contact:Maia Kelly-MolinaDirector of Strategic CommunicationsAlliant University
More news about: Alliant University
Mar 16, 2026, 07:04 ET Matillion Appoints Tim O'Neil as Chief Revenue Officer
AI-native acceleration with Maia. Organizations including Merck, EDF, and GE Healthcare are using Maia to automate data workflows that previously demanded significant manual effort — freeing their teams to focus on building data products rather than managing pipeline complexity. Maia works natively within
More news about: Matillion Ltd
Mar 02, 2026, 07:00 ET Compugen Reports Fourth Quarter and Full Year 2025 Results
COM701 MAIA-ovarian and of GS-0321 Phase 1 and expanded our clinical footprint across the U.S., Israel and France in the MAIA-ovarian clinical trial. At ESMO 2025, we presented pooled COM701 data from 3 platinum resistant ovarian cancer trials that we believe support the rationale for our MAIA-ovarian
More news about: Compugen Ltd.
Feb 19, 2026, 14:00 ET MAIA Pharmaceuticals Selected by Asahi Kasei Pharma to Advance Teribone™ for US Osteoporosis Patients
https://www.asahikasei-pharma.co.jp/en/.About MAIA Pharmaceuticals, Inc.Founded in 2013 and headquartered in Princeton, New Jersey, MAIA Pharmaceuticals is a specialty pharmaceutical company focused on advancing differentiated and clinically meaningful therapies. MAIA specializes in identifying proven
More news about: MAIA Pharmaceuticals, Inc.
Feb 12, 2026, 09:00 ET Pentera Named GM Sectec Partner of the Year, Capping a Breakout Year of Joint Success Across LATAM
[email protected] business inquiries:Manoella MaiaChannel Account [email protected]
More news about: Pentera